Ionis Pharmaceuticals Inc
IONS· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2012 | Q3 2011 | Q3 2010 | Q3 2009 |
|---|---|---|---|---|
| Revenue | $11.60M | $20.71M | $28.62M | $26.77M |
| Net Income | — | — | -$12.45M | -$11.58M |
| EPS Diluted | -$0.37 |
Ionis Pharmaceuticals Inc · CIK 874015 · Engraved from SEC EDGAR
| -$0.27 |
| -$0.13 |
| -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.